Exploiting binding-site arginines in drug design: Recent examples
- PMID: 32730944
- DOI: 10.1016/j.bmcl.2020.127442
Exploiting binding-site arginines in drug design: Recent examples
Abstract
Active or allosteric site arginines can form diverse interactions with ligands including different types of cation-π interactions, H-bond interactions and non-bond, non-canonical interactions. This provides many opportunities for creative structure-based drug design to improve potency, introduce novelty, and modulate MoA (mode of action), and even to achieve selectivity. This digest will use some recent drug targets of interest as examples to illustrate different types of interactions and how these interactions impact on potency, MoA, and selectivity.
Keywords: Arginine; Non-canonical interaction; Protein ligand interaction; Structure-based drug design.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
Research Materials
Miscellaneous
